You are here

  • Home
  • Archive
  • Volume 70, Issue 4
  • Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

Article info

Article menu
Clinical and epidemiological research
Extended report
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Free

Authors

  1. Correspondence to Dr Jeffrey D Greenberg, Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY 10003, USA; jeffrey.greenberg{at}nyumc.org
View Full Text

Citation

Greenberg JD, Kremer JM, Curtis JR on behalf of the CORRONA Investigators, et al
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2011;70:576-582.

Publication history

  • Accepted October 3, 2010
  • First published November 24, 2010.
Online issue publication 
November 02, 2019

Article Versions

  • Web Only Data

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions